These results suggest that the primary lung tumor in our case may mount a protective immune response to attack tumor cells and have the potential to respond to immune checkpoint inhibitor monotherapy or combination therapy with an immune checkpoint inhibitor and chemotherapies despite the negative expression of PD-L1 in tumor cells [36,38,39,40]. Here, CD274 is linked to neoplasm.